Philippe Dumont - 01 Mar 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Role
Director
Signature
Suzette McNally, Attorney-in-Fact for Philippe Dumont
Issuer symbol
CBUS
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
01 Jun 2023, 20:11:13 UTC
Previous filing
15 Jun 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -5,000 -100% 0 01 Mar 2023 Common Stock 5,000 $4.55 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +5,000 5,000 01 Mar 2023 Common Stock 5,000 $4.55 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -10,291 -100% 0 01 Mar 2023 Common Stock 10,291 $4.22 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +10,291 10,291 01 Mar 2023 Common Stock 10,291 $4.22 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -32,700 -100% 0 01 Mar 2023 Common Stock 32,700 $0.3032 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +32,700 32,700 01 Mar 2023 Common Stock 32,700 $0.3032 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Philippe Dumont is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.